Your browser doesn't support javascript.
loading
Intravenous ofatumumab treatment of multiple sclerosis and related disorders: An observational study.
El Mahdaoui, Sahla; Romme Christensen, Jeppe; Magyari, Melinda; Wandall-Holm, Malthe Faurschou; Sellebjerg, Finn.
Afiliação
  • El Mahdaoui S; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark. Electronic address: sahla.el.mahdaoui.01@regionh.dk.
  • Romme Christensen J; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Magyari M; Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Wandall-Holm MF; Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Mult Scler Relat Disord ; 68: 104246, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36279600

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Esclerose Múltipla / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Esclerose Múltipla / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article